Phase IIa Safety and Immunogenicity of a Therapeutic Vaccine, TA‐GW, in Persons with Genital Warts
Open Access
- 1 March 1999
- journal article
- clinical trial
- Published by Oxford University Press (OUP) in The Journal of Infectious Diseases
- Vol. 179 (3) , 612-618
- https://doi.org/10.1086/314616
Abstract
A fusion protein vaccine consisting of human papillomavirus 6 L2E7 with Alhydrogel was developed for the treatment of genital warts. Twenty-seven subKeywords
This publication has 0 references indexed in Scilit: